Sign in

CIK 0001570562

  • Accelerated filer

Evolus, Inc.

Sign in to watch
Ticker
EOLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
461385614
Phone
+1 949-284-4555
Business address
520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
Former names
Evolus, Inc.
  1. 4 Open-market buy 10% owner bought 115,000 shares at an average $10.63 ($1,222,137)
  2. 4 Open-market sale MOATAZEDI DAVID sold 70,445 shares at an average $11.13 ($783,810)
  3. 4 Open-market buy 10% owner bought 114,714 shares at an average $11.18 ($1,282,751)
  4. 4 Open-market buy 10% owner bought 65,286 shares at an average $10.87 ($709,452)
  5. 4/A Open-market sale Chief Marketing Officer sold 5,362 shares at $11.18 ($59,944)
  6. 4/A Open-market sale SILVERNAIL LAUREN P sold 14,293 shares at $11.18 ($159,774)
  7. 4/A Open-market sale MOATAZEDI DAVID sold 41,763 shares at $11.18 ($466,839)
  8. 4 Open-market sale SILVERNAIL LAUREN P sold 14,293 shares at $11.18 ($159,774)
  9. 4 Open-market sale Avelar Rui sold 14,293 shares at $11.18 ($159,789)
  10. 4 Open-market sale Chief Marketing Officer sold 5,362 shares at $11.18 ($59,944)
  11. 4 Open-market sale MOATAZEDI DAVID sold 41,763 shares at $11.18 ($466,839)
  12. 4 Grant or award Director acquired 18,011 shares (grant or award)
  13. 4 Grant or award MOATAZEDI DAVID acquired 48,853 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 19,313 shares (grant or award)
  18. 4 Grant or award Director acquired 19,313 shares (grant or award)
  19. 4 Grant or award Director acquired 19,313 shares (grant or award)
  20. 4 Grant or award Director acquired 19,313 shares (grant or award)

Page 8 of 13 · 252 filings